This invention relates to a method for the preparation of sertraline hydrochloride, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphtalenam- ine hydrochloride, in its crystalline form II.
RELATED APPLICATIONS
This application claims priority to U.S. Provisional application No. 60/487,292 filed Jul. 15, 2003 which is incorporated herein by reference in its entirety.